EXPANDABLE SUPPORT DEVICE AND METHOD OF USE

[0001] This application is a divisional application of U.S. patent application Ser. No. 12/260,971, filed Oct. 29, 2008, which is a continuation-in-part of PCT international Application No. PCT/US2007/067967, filed May 1, 2007, which claims the benefit of U.S. Provisional Application No. 60/796,915, filed May 1, 2006, which are herein incorporated by reference in their entireties.

[0002] 1. Field of the Invention

[0003] This invention relates to devices for providing support for biological tissue, for example to repair spinal compression fractures, and methods of using the same.

[0004] An expandable support device for performing completely or partially implantable spinal repair is disclosed. The device has a first strut and a second strut attached to, and/or integral with, the first strut. The first strut is substantially deformable. The second strut can be substantially inflexible.

[0005] The device can be configured to expand in a radial direction during deployment in a bone. The device can be configured to contract in a longitudinal direction during deployment in a bone.

[0006] An expandable support device for repairing damaged bone is disclosed. The expandable support device can have a longitudinal axis. The expandable support device can have a first strut having a first strut cross-section. The expandable support device can have a second strut attached to, and/or integral with, the first strut. The first strut can be substantially deformable. The first strut cross-section can be configured to encourage bone growth toward the longitudinal axis.

[0007] The expandable support device can have a bone growth material. The first strut can have the bone growth material. The first strut can be coated with the bone growth material. The bone growth material can circumferentially surround the first strut cross-section.

[0008] The first strut can have a first strut first side closer to the longitudinal axis and a first strut second side farther from the longitudinal axis than the first strut first side, and the bone growth material can be on the first strut first side. The first strut second side can be substantially uncoated with the bone growth material.

[0009] The first strut cross-section can have a needle tip. The first strut cross-section can have a chisel tip. The first strut can have a thread extending radially therefrom. The first strut can have a longitudinal vane extending radially therefrom.

[0010] An apparatus for deploying and retrieving an expandable support device is a bone is disclosed. The apparatus can have a deployment rod. The deployment rod can have an expandable support device engager. The apparatus can have a retrieval sheath translatably slidable with respect to the deployment rod. The retrieval sheath can be configured to radially compress the expandable support device.

[0011] A method of retrieving a deployed expandable support device from a bone is disclosed. The method can include holding the expandable support device. The method can include translating a sheath over the expandable support device. Translating the sheath can include translating a rigid sheath. Holding can include holding a first end of the expandable support device. Translating can include radially compressing the expandable support device. The method can include translating the expandable support device out of the bone.

[0012] A method of deploying an expandable support device having a radius in a bone is disclosed. The method can include positioning the expandable support device in the bone. The method can also include radially expanding the expandable support device through the bone. The method can also include creating track voids. The method can also include deploying a material into the track voids, wherein the material encourages bone growth.

[0048] FIGS. 1, 40, 51, 45, 47, 56 and 57, are shown with exemplary length scales labeled in 10 mm increments and tabbed in ½ mm and 1 mm increments.

[0049] Dimensions shown in FIGS. 15, 16, 17, 19 and 21 are merely examples. All dimensions can be from about 25% to about 400% of the dimensions shown in the figures, more narrowly from about 75% to about 125% of the dimensions shown in the figures.

[0050] FIG. 1 illustrates an expandable support device 2 in a radially expanded and longitudinally contracted configuration. The expandable support device 2 can be configured to be deployed in a treatment site, such as a bone, to provide mechanical support, for example to treat compression or other fractures or other structural bone failures. The expandable support device 2 can have a radially contracted and longitudinally expanded configuration, for example before deployment into a treatment site. The expandable support device 2 can have a radially expanded and longitudinally contracted configuration, for example after deployment into the treatment site.

[0051] The expandable support device 2 can have a longitudinal axis 4. The expandable support device 2 can have a distal port 6 at a longitudinally distal end and a proximal port 8 at a longitudinally proximal end. The expandable support device 2 can have a device radial side 10. The device side 10 can be substantially the surface defined by the cells 12 and pores 14, and for example, can exclude the proximal port 8 and the distal port 6.

[0052] The expandable support device 2 can have a number of struts 16 connected at joints 18. The struts 16 can be rigid and/or flexible. The struts 16 can be deformable and/or resilient. The joints 18 can be rigid and/or flexible. The joints 18 can be deformable and/or resilient.

[0053] The struts 16 and joints 18 can form enclosed shapes, such as cells 12. The cell 12 can dynamically act as a four-bar system (e.g., if the cell has four struts), five-bar system (e.g., if the cell has five struts), or another closed dynamic system correlating with the number of struts 16 and joints 18 of the cell.

[0054] The interior area of each cell can be a pore 14. The pores 14 can be open to the radial center of the expandable support device 2. The pores 14 can be substantially unobstructed. The pores 14 can encourage tissue (e.g., bone) growth toward the lumen or longitudinal channel of the expandable support device 2.

[0055] The device side can have a device side area 10. The radially (e.g., with respect to the longitudinal axis) external area joints 18 and struts 16 can be a solid surface area. The radially (e.g., with respect to the longitudinal axis) external area of the pores 14 can be a pore area. The ratio of the pore area to the device side area can be a pore ratio. With the expandable support device 2 in a radially expanded configuration, the pore ratio can be from about 20% to about 99%, more narrowly from about 50% to about 98%, yet more narrowly from about 75% to about 95%, for example about 80% or about 85% or about 90%.

[0056] Additional exemplary variations, features, elements and methods of use of the expandable support device and tools for deploying the expandable support device are described in PCT patent application Ser. Nos. PCT/US05/034115 filed 21 Sep. 2005; PCT/US05/034742 filed 27 Sep. 2005; PCT/US05/034728 filed 27 Sep. 2005; PCT/US2005/037126 filed 12 Oct. 2005; and U.S. Provisional Patent Application Numbers 60/675,543 filed 27 Apr. 2005; 60/741,201 filed 1 Dec. 2005; 60/741,197 filed 1 Dec. 2005; 60/751,882 filed 19 Dec. 2005; 60/675,512 filed 27 Apr. 2005; 60/752,180 filed 19 Dec. 2005; 60/699,577 tiled 14 Jul. 2005; 60/699,576 filed 14 Jul. 2005; 60/754,492 filed 28 Dec. 2005; 60/751,390 filed 15 Dec. 2005; 60/752,186 filed 19 Dec. 2005; 60/754,377 filed 27 Dec. 2005; 60/754,227 filed 28 Dec. 2005; 60/752,185 filed 19 Dec. 2005; and 60/752,182 filed 19 Dec. 2005; all of which are incorporated by reference herein in their entireties.

[0057] FIGS. 2, 3 and 4 illustrate that a distal end of the expandable support device 2 can be attached to and/or integral with a distal releasable attachment element 20. The proximal end of the expandable support device 2 can be attached to and/or integral with a proximal releasable attachment element 22.

[0058] FIG. 5 illustrates that the distal releasable attachment element 20 can be fixedly or removably attached to the expandable support device 2 at one or more attachment points 24. The attachment points 24 can be welds, press fits, adhesive, integrated elements, or combinations thereof.

[0059] FIG. 6 illustrates that the proximal releasable attachment element 22 can be fixedly or removably attached to the expandable support device 2 at one or more attachment points 24. The proximal releasable attachment element 22 can have a varying outer diameter along its length. The outer diameter of the proximal releasable attachment element 22 act as an interface, for example to be engaged by a deployment tool.

[0060] FIG. 7 illustrates that the expandable support device 2 can have a radially contracted configuration. The expandable support device 2 can have a contracted diameter 26 and an expanded length 28. The expandable support device 2 can have a substantially cylindrical shape.

[0061] FIG. 8 illustrates that the cell 12 can have at least one longitudinal cell angle 30. The longitudinal cell angle 30 can be the angle formed between a first strut 32 and a second strut 34. The longitudinal cell angle 30 can face in a substantially parallel, or otherwise aligned, direction to the longitudinal axis 4.

[0062] The cell 12 can have at least one transverse cell angle 36. The transverse cell angle 36 can be the angle formed between the first strut 32 and a third strut 38. The transverse cell angle 36 can face in a substantially perpendicular or otherwise misaligned direction to the longitudinal axis 4. The transverse cell angle 36 can face in a substantially perpendicular or otherwise misaligned direction to the longitudinal cell angle 30.

[0063] FIG. 9 illustrates that the expandable support device 2 can have a radially expanded configuration. The expandable support device 2 can have an expanded diameter 40 and a contracted length 42. The expanded diameter 2 can be greater than the contracted diameter 26. The contracted length 42 can be less than the expanded length 28. The expandable support device 2 can have a substantially spherical, toroid or cubical shape.

[0064] FIG. 10 illustrates that transverse cell angle 36 in the cell 12 from the expandable support device 2 having the radially expanded configuration can be smaller than the cell angle 36 in the cell from the expandable support device 2 having the radially contracted configuration. The longitudinal cell angle 30 in the cell 12 from the expandable support device 2 having the radially expanded configuration can be larger than the cell angle 36 in the cell 12 from the expandable support device 2 having the radially contracted configuration.

[0065] FIG. 11 illustrates that the expandable support device 2 can have releasable attachment elements at the distal and/or proximal ends. For example, the expandable support device 2 can have distal device threads 44 and/or proximal device threads 46. The device mid-length section 48 can be bare of threads. The releasable attachment elements can be controllably removably attached to a deployment tool and/or the remainder of the expandable support device 2.

[0066] FIG. 12 illustrates that the device threads 50 can be continuous and/or substantially continuous from the proximal to the distal end (i.e., including the device mid-length section 48) of the expandable support device 2.

[0067] FIGS. 13 and 14 illustrates that the releasable attachment element, such as the proximal releasable attachment element 22, can be one or more device keys 52. The device keys 52 can have device key distal ends 54. The device key distal ends 54 can protrude in the distal direction and, for example can be sharpened. Device key ports 56 can be angularly between the device keys 52. The releasable attachment devices can be threads, keys, tabs, luers, or combinations thereof.

[0068] FIGS. 15, 16, 17 and 18 illustrate that the distal releasable attachment element 20 can have an internal channel 58. The internal channel 58 can have an internal channel diameter 59. The internal channel diameter 59 can be from about 1 mm (0.4 in.) to about 3 mm (0.1 in.), for example about 1.99 mm (0.0785 in.)

[0069] The distal releasable attachment element 20 can have distal device threads 44 (shown in FIG. 18).

[0070] The distal releasable attachment element 20 can have a sharpened distal end. The sharpened distal end can be used, for example, to push through bone during use. The sharpened distal end can have a sharpened distal end angle 61. The sharpened distal end angle 61 can be from about 20° to about 70°, for example about 45°.

[0071] The distal releasable attachment element 20 can have a distal releasable attachment element length 63. The distal releasable attachment element length 63 can be from about 13 mm (0.051 in.) to about 5 mm (0.2 in.), for example about 2.92 mm (0.115 in.).

[0072] The distal releasable attachment element 20 can have a distal releasable attachment element outer diameter 65. The distal releasable attachment outer diameter 65 can be from about 2.5 mm (0.098 in.) to about 10 mm (0.4 in.), for example about 4.78 mm (0.188 in.).

[0073] The distal releasable attachment element 20 can have an inner chamfer 67. The inner chamfer 67 can have an angle of about 45° from the adjacent sides and can have a length of about 0.2 mm (0.009 in.).

[0074] FIGS. 19, 20, 21 and 22 illustrate that the proximal releasable attachment element 22 can have the internal channel 58. The distal releasable attachment element 20 can have distal device threads 44 (shown in FIG. 18). The distal releasable attachment element 20 can have an engagable (e.g., lipped or notched) proximal end. The engagable proximal end can be configured, for example, to releasably engage a deployment tool.

[0075] FIG. 23 illustrates that the struts 16 can define a circular or oval cross-section of the expandable support device 2 in a given cross-section A-A. The pores 14 can have pore angles 60 with respect to the longitudinal axis 4 in cross-section, as shown. The pore angles 60 can vary around the cross-section of the expandable support device 2 (i.e., as the pores get closer to distal and proximal joints, the pore angles approach zero). The struts 16 can have uniform (as shown) or various cross-sectional configurations. The struts 16 can have substantially circular cross-sections, as shown in FIG. 10.

[0076] FIG. 24 illustrates that the struts 16 can form a square or rectangular cross-section of the expandable support device 2 in a given cross-section A-A. One or more of the struts 16 can have markers 62, such as radiopaque and/or echogenic markers. The markers 62 can be unique for each strut 16. For example, the markers 62 can identify the deployment orientation, as shown (e.g., arrows pointing in the up direction for deployment, with the top strut's marker showing a top arrow; the left strut's marker showing an arrow with only a left arrow-end; the right strut's marker showing an arrow with only a left arrow-end; and the bottom strut's marker showing an arrow with the arrowhead near the bottom of the arrow).

[0077] FIG. 25 illustrates that the struts 16 can have substantially square or rectangular cross-sectional configurations. The struts 16 and joints 14 (not shown, and understood to be substantially represented when describing the struts in cross-sections A-A) can have first rectilinear axes 64. The first rectilinear axes 64 can substantially or completely intersect the longitudinal axis 4 in a given cross-section A-A. Expandable support devices 2 that do not have circular or ovular transverse cross-sections (i.e., the shapes defined by the struts and pores shown in cross-section A-A), such as square, rectangular, triangular transverse cross-sections, or combinations thereof, can have one or more struts 16 with rectilinear axes 64 that do not substantially intersect the longitudinal axis 4 in a given cross-section A-A.

[0078] FIG. 26 illustrates that the struts 16 and joints 14 (not shown) can have diametric or diagonal axes 66 in a given cross-section A-A. The diametric or diagonal axes 66 can substantially or completely intersect the longitudinal axis 4. Expandable support devices 2 that do not have circular or ovular transverse cross-sections (i.e., the shapes defined by the struts and pores shown in cross-section A-A), such as square, rectangular, triangular transverse cross-sections, or combinations thereof, can have one or more struts 16 with diametric or diagonal axes 66 that do not substantially intersect the longitudinal axis 4 in a given cross-section A-A. The struts 16 can have square or rectangular cross-sectional configurations.

[0079] FIG. 27 illustrates that the struts 16 and joints 14 (not shown) can have rectangular or oval (as shown) cross-sectional configurations or other cross-sectional configurations with primary and secondary axes. The oval cross-sections can each have a major (i.e., primary) axis 68. The oval cross-sections can each have a minor (i.e., secondary) axis 70 in a given cross-section A-A. The major axes 68 can substantially or completely intersect the longitudinal axis 4. The minor axes 70 can substantially or completely intersect the longitudinal axis 4. Expandable support devices 2 that do not have circular or ovular transverse cross-sections (i.e., the shapes defined by the struts and pores shown in cross-section A-A), such as square, rectangular, triangular transverse cross-sections, or combinations thereof, can have one or more struts 16 with major 68 and/or minor axes 70 that do not substantially traverse the longitudinal axis 4 in a given cross-section A-A.

[0080] FIG. 28 illustrates that the struts 16 and joints 14 (not shown) can have triangular (e.g., diagonal, right, isosceles, equilateral) cross-sectional configurations. The triangular configurations can each have the major axis 68.

[0081] FIG. 29 illustrates that the struts 16 and joints 14 (not shown) can have needle tips 72, for example with a triangular configuration cross-sectional configuration. The needle tip 72 can have a first needle side 74 and a second needle side 76. One or both needle sides can be concave inward. The needle tip 72 can have a needle tip angle from about 0.1° to about 30°, more narrowly from about 0.5° to about 25°, yet more narrowly from about 2° to about 20°, for example about 5° or about 10° or about 15°.

[0082] FIG. 30 illustrates that the struts 16 and joints 14 (not shown) can each have a first needle tip 78 pointed radially outward, and a second needle tip 80 pointed radially inward. The major axis 68 can be the major axis for the first and second needle tips 78, 80.

[0083] FIG. 31 illustrates that the struts 16 and joints 14 (not shown) can have a first tip 82 and a second tip 84 along the major axis 68. The struts 16 can be of nominal or otherwise substantially no thickness in directions other than the major axis 68.

[0084] FIG. 32 illustrates that the struts 16 and joints 14 (not shown) can have a nail-like configuration. The struts 16 can have a tip 86 running on the major axis 68. The struts 16 can have a head 88, for example, at about a 90° angle to the tip 86 and/or to the major axis 68.

[0085] FIG. 33 illustrates that the struts 16 and joints 14 (not shown) can have chisel tips 90. The struts 16 can have quadrilateral (e.g., bicentric quadrilateral, cyclic quadrilateral, orthocentric quadrilateral, rational quadrilateral), parallelogram (e.g., medial parallelogram), rhombus (e.g., golden rhombus), kite, lozenge, trapezoid (e.g., isosceles trapezoid), tetrahedron cross-sectional configuration or combinations thereof.

[0086] FIG. 34 illustrates that the struts 16 and joints 14 (not shown) can have randomly-shaped surface 92 configurations. The randomly-shaped surface 92 configurations can have an irregular surface defined by a random or quasi-random configuration.

[0087] FIG. 35 illustrates that the struts 16 can have a textured (e.g., non-randomly surfaced) surface 94 configuration. For example, the textured surface 94 configuration can have a knurled, convex or concave dimpled or bumped, transversely and/or longitudinally and/or diagonally checkered or grooved (as shown), or brushed configuration, or combinations thereof.

[0088] FIG. 36 illustrates that the struts 16 can each have one or more threads and/or longitudinal vanes 96 attached to or integral therewith. The threads and/or vanes 96 can extend radially toward the longitudinal axis 4. The threads and/or vanes 96 can have a coating or be made partially or completely from any material listed herein, such as cements and/or fillers and/or glues (e.g., bone morphogenic protein, morselized bone, additional examples listed infra), such as for soliciting or otherwise encouraging bone growth. The threads and/or vanes 96 can be flexible or rigid. The threads and/or vanes 96 can be resilient and/or deformable. The threads and/or vanes 96 can be made in whole or part from a bioresorbable, bioabsorbable or biodegradable material. The various threads and/or vanes 96 can have uniform or variable lengths.

[0089] FIG. 37 illustrates that the struts 16 can be wholly (as shown) or partially coated and/or otherwise covered by a coating and/or matrix 98 of any material listed herein. FIG. 38 illustrates that the struts 16 can be coated and/or be otherwise covered by a material listed herein on the side of the strut 16 facing the longitudinal axis 4. The side of the strut 16 not facing the longitudinal axis 4 can have no coating neither/nor be otherwise covered by a material other than the material of the original non-coated/covered strut.

[0090] Any or all elements of the expandable support device 2 and/or deployment tool and/or other devices or apparatuses described herein can be made from, for example, a single or multiple stainless steel alloys, nickel titanium alloys (e.g., Nitinol), cobalt-chrome alloys (e.g., ELGILOY® from Elgin Specialty Metals, Elgin, Ill.; CONICHROME® from Carpenter Metals Corp., Wyomissing, Pa.), nickel-cobalt alloys (e.g., MP35N® from Magellan Industrial Trading Company, Inc., Westport, Conn.), molybdenum alloys (e.g., molybdenum TZM alloy, for example as disclosed in International Pub. No. WO 03/082363 A2, published 9 Oct. 2003, which is herein incorporated by reference in its entirety), tungsten-rhenium alloys, for example, as disclosed in International Pub. No. WO 03/082363, polymers such as polyethylene teraphathalate (PET), polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, Del.), polypropylene, aromatic polyesters, such as liquid crystal polymers (e.g., Vectran, from Kuraray Co., Ltd., Tokyo, Japan), ultra high molecular weight polyethylene (i.e., extended chain, high-modulus or high-performance polyethylene) fiber and/or yarn (e.g., SPECTRA® Fiber and SPECTRA® Guard, from Honeywell International, Inc., Morris Township, N.J., or DYNEEMA® from Royal DSM N.V., Heerlen, the Netherlands), polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), polyether ketone (PEK), polyether ether ketone (PEEK), poly ether ketone ketone (PEKK) (also poly aryl ether ketone ketone), nylon, polyether-block co-polyamide polymers (e.g., PEBAX® from ATOFINA, Paris, France), aliphatic polyether polyurethanes (e.g., TECOFLEX® from Thermedics Polymer Products, Wilmington, MA), polyvinyl chloride (PVC), polyurethane, thermoplastic, fluorinated ethylene propylene (FEP), absorbable or resorbable polymers such as polyglycolic acid (PGA), poly-L-glycolic acid (PLGA), polylactic acid (PLA), poly-L-lactic acid (PLLA), polycaprolactone (PCL), polyethyl acrylate (PEA), polydioxanone (PDS), and pseudo-polyamino tyrosine-based acids, extruded collagen, silicone, zinc, echogenic, radioactive, radiopaque materials, a biomaterial (e.g., cadaver tissue, collagen, allograft, autograft, xenograft, bone cement, morselized bone, osteogenic powder, beads of bone) any of the other materials listed herein or combinations thereof. Examples of radiopaque materials are barium sulfate, zinc oxide, titanium, stainless steel, nickel-titanium alloys, tantalum and gold.

[0091] Any or all elements of the expandable support device 2 and/or deployment tool and/or other devices or apparatuses described herein, can be, have, and/or be completely or partially coated with agents and/or a matrix a matrix for cell ingrowth or used with a fabric, for example a covering (not shown) that acts as a matrix for cell ingrowth. The matrix and/or fabric can be, for example, polyester (e.g., DACRON® from E. I. Du Pont de Nemours and Company, Wilmington, DE), polypropylene, PTFE, ePTFE, nylon, extruded collagen, silicone or combinations thereof.

[0092] The expandable support device 2 and/or deployment tool and/or elements of the expandable support device 2 and/or elements of the deployment tool and/or other devices or apparatuses described herein and/or the fabric can be filled, coated, layered and/or otherwise made with and/or from cements, fillers, glues, and/or an agent delivery matrix known to one having ordinary skill in the art and/or a therapeutic and/or diagnostic agent. Any of these cements and/or fillers and/or glues can be osteogenic and osteoinductive growth factors.

[0093] Examples of such cements and/or fillers includes bone chips, demineralized bone matrix (DBM), calcium sulfate, coralline hydroxyapatite, biocoral, tricalcium phosphate, calcium phosphate, polymethyl methacrylate (PMMA), biodegradable ceramics, bioactive glasses, hyaluronic acid, lactoferrin, bone morphogenic proteins (BMPs) such as recombinant human bone morphogenetic proteins (rhBMPs), other materials described herein, or combinations thereof.

[0094] The agents within these matrices can include any agent disclosed herein or combinations thereof, including radioactive materials; radiopaque materials; cytogenic agents; cytotoxic agents; cytostatic agents; thrombogenic agents, for example polyurethane, cellulose acetate polymer mixed with bismuth trioxide, and ethylene vinyl alcohol; lubricious, hydrophilic materials; phosphor cholene; anti-inflammatory agents, for example non-steroidal anti-inflammatories (NSAIDs) such as cyclooxygenase-1 (COX-1) inhibitors (e.g., acetylsalicylic acid, for example ASPIRIN® from Bayer AG, Leverkusen, Germany; ibuprofen, for example ADVIL® from Wyeth, Collegeville, Pa.; indomethacin; mefenamic acid), COX-2 inhibitors (e.g., VIOXX® from Merck & Co., Inc., Whitehouse Station, N.J.; CELEBREX® from Pharmacia Corp., Peapack, N.J.; COX-1 inhibitors); immunosuppressive agents, for example Sirolimus (RAPAMUNE®, from Wyeth, Collegeville, Pa.), or matrix metalloproteinase (MMP) inhibitors (e.g., tetracycline and tetracycline derivatives) that act early within the pathways of an inflammatory response. Examples of other agents are provided in Walton et al, Inhibition of Prostoglandin E₂ Synthesis in Abdominal Aortic Aneurysms, Circulation, Jul. 6, 1999, 48-54; Tambiah et al, Provocation of Experimental Aortic Inflammation Mediators and Chlamydia Pneumoniae, Brit. J. Surgery 88 (7), 935-940; Franklin et al, Uptake of Tetracycline by Aortic Aneurysm Wall and Its Effect on Inflammation and Proteolysis, Brit. J. Surgery 86 (6), 771-775; Xu et al, Sp1 Increases Expression of Cyclooxygenase-2 in Hypoxic Vascular Endothelium, J. Biological Chemistry 275 (32) 24583-24589; and Pyo et al, Targeted Gene Disruption of Matrix Metalloproteinase-9 (Gelatinase B) Suppresses Development of Experimental Abdominal Aortic Aneurysms, J. Clinical Investigation 105 (11), 1641-1649 which are all incorporated by reference in their entireties.

[0095] FIG. 39 illustrates that a first deployment tool 100 can enter through the subject's back. The first deployment tool 100 can enter through a first incision 102 in skin 104 on the posterior side of the subject near the vertebral column 106. The first deployment tool 100 can be translated, as shown by arrow 108, to position a first expandable support device 110 into a first damage site 112. The first access port 114 can be on the posterior side of the vertebra 116.

[0096] A second deployment tool 118 can enter through a second incision 120 (as shown) in the skin 104 on the posterior or the first incision 102. The second deployment tool 118 can be translated through muscle (not shown), around nerves 122, and anterior of the vertebral column 106. The second deployment tool 118 can be steerable. The second deployment tool 118 can be steered, as shown by arrow 124, to align the distal tip of the second expandable support device 126 with a second access port 128 on a second damage site 130. The second access port 128 can face anteriorly. The second deployment tool 118 can translate, as shown by arrow 132, to position the second expandable support device 126 in the second damage site 130.

[0097] The vertebra 116 can have multiple damage sites 112, 130 and expandable support devices 2 deployed therein. The expandable support devices 2 can be deployed from the anterior, posterior, both lateral, superior, inferior, any angle, or combinations of the directions thereof.

[0098] As shown in applications incorporated by reference herein, the expandable support device 2 can be inserted in the vertebra 116 in a radially contracted configuration. The expandable support device 2 can then be radially expanded.

[0099] FIG. 40 illustrates the expandable support device 2 in a partially deployed, radially expanded configuration in the vertebra 116. The expandable support device 2 can be removably attached to the deployment tool 134. The deployment tool 134 can have a deployment rod sheath 136, as shown. The expandable support device 2 can be attached to a deployment rod and/or the deployment rod sheath 136.

[0100] FIG. 41 illustrates FIG. 40 with the deployment tool 134 partially disassembled for illustrative purposes. The deployment tool 134 can have a recovery sheath 138. The recovery sheath 138 can be slidably attached over the deployment rod and/or the deployment rod sheath 136. The recovery sheath 138 can be hollow cylinder. The recovery sheath 138 can be translatably controlled by the deployment tool 134. The deployment rod sheath 136 can be slidably or fixedly attached to the deployment rod and/or the remainder of the deployment tool 134.

[0101] FIG. 42 illustrates that a deployment tool 134 can have a distal tool head 140 at the distal end of a distal tool shaft 142. The distal tool shaft 142 can be removably attached to the distal end of the expandable support device 2 (e.g., interference fit and/or threadably attached). The deployment tool 134 can have an engagement element 144 that can be removably attached (e.g., threadably attached and/or interference fit) to the proximal end of the expandable support device 2. For example, one or more struts 16 at the proximal end of the expandable support device 2 can be releasably compressed between the engagement element 144 and a proximal anvil 146 that can be attached to or integral with the deployment rod 148.

[0102] The distal tool shaft 142 can be translated proximally, as shown by arrow 150. The distal tool head 140 and the proximal anvil 146 can longitudinally compress, as shown by arrow 152, the expandable support device 2. The expandable support device 2 can then radially expand, as shown by arrow 154.

[0103] FIG. 43 illustrates that the distal tool head 140 can be removably attached (e.g., unscrewable, or unlockable—as a key, or retractable (e.g., rotatably, or otherwise compressably or condensably)) attached to the distal tool shaft 142. The distal tool head 140 can be retracted and the distal tool shaft 142 can be translated out of the expandable support device, as shown by arrow 150.

[0104] FIGS. 44 and 45 illustrate that the expandable support device 2 can be in a radially expanded configuration in the vertebra. The expandable support device 2 can be attached to the deployment tool 134 (e.g., never released during deployment or released and re-attached/re-engaged). The expandable support device 2 can be in an incorrect location, improperly radially expanded, or otherwise desirous of being removed, repositioned, or otherwise redeployed. The recovery sheath 138 can be translated, as shown by arrow 156, toward and onto the expandable support device 2. The expandable support device 2, substantially other than the recovery sheath 138, can be substantially stationary with respect to the expandable support device 2. The recovery sheath 138 can begin to radial compress, as shown by arrows 158, the expandable support device 2.

[0105] FIG. 46 illustrates that the recovery sheath 138 can be additionally translated, as shown by arrow 156, over the expandable support device 2. The expandable support device 2 can radially contract, as shown by arrows 158, for example into a substantially radially contracted configuration. The deployment tool 134 can then by translated, as shown by arrow 160, away from the vertebra 116. The deployment tool 134 can reposition the expandable support device 2 and retract the recovery sheath 138, and for example radially expand the expandable support device 2 in the vertebra 116 (e.g., with or without removing the expandable support device from the vertebra).

[0106] FIG. 47 illustrates that the deployment tool 134 can completely remove the expandable support device 2 from the vertebra 116. The same or a different expandable support device 2 can then be deployed into the vertebra 116.

[0107] FIG. 48 illustrates that the expandable support device 2 can be releasably attached to the deployment tool 134. The deployment tool 134 can have the deployment rod 148 extending from the deployment rod sheath 136. The deployment tool 148 can have distal rod threads 162. The distal rod threads 162 can be releasably (e.g., rotatably) attached to the distal device threads 44. The deployment rod 148 can have proximal rod threads 164 between the distal rod threads 162 and the proximal device threads 46. The deployment tool 134 can have a deployment rod sheath 136. The deployment rod sheath 136 can abut, interference fit or otherwise attach to the proximal end of the expandable support device 2.

[0108] FIG. 49 illustrates that the deployment rod 148 can be forcibly proximally translated, as shown by arrow 166. The expandable support device 2 can then be longitudinally compressed, as shown by arrow 168, between the distal device threads 44 and the deployment rod sheath 136 and/or other proximal attachment device (not shown). The expandable support device 2 can radially expand, as shown by arrows 170, for example due to the longitudinal compression 152.

[0109] FIG. 50 illustrates that, with the expandable support device 2 in a radially expanded configuration, the deployment rod 148 can be proximally translated, as shown by arrow 166. The translation of the deployment rod can, for example, be due to rotation of the deployment rod 148, as shown by arrow 172, and the threading of distal rod threads 162 through the distal device threads 44.

[0110] The proximal rod threads 164 can thread into the proximal device threads 46. If the placement and configuration of the expandable support device 2 is satisfactory, the proximal rod threads 164 can be rotatably removed from the proximal device threads 46. The deployment device can then be removed entirely. If the placement and configuration of the expandable support device 2 is not satisfactory, the expandable support device 2 can be radially contracted and removed from the treatment site, as described infra.

[0111] FIG. 51 illustrates that the recovery sheath 138 can be translated, as shown by arrow 156, toward the expandable support device 2, and/or the expandable support device 2 can be translated (e.g., via translation of the attached deployment rod 148) toward the recovery sheath 138.

[0112] FIG. 52 illustrates that the recovery sheath 138 can be translated onto the expandable support device 2, as shown by arrow 171, and/or the expandable support device 2 (e.g., via translation of the attached deployment rod 148) can be translated, as shown by arrow 173, into the recovery sheath 138 and/or the expandable support device 2 can be translated toward the recovery sheath 138. As the expandable support device 2 is translated into the recovery sheath 138, the expandable support device 2 can be radially contracted, as shown by arrows 174. When the expandable support device 2 is sufficiently radially contracted 174 and/or in the recovery sheath 138, the deployment tool 134 and the expandable support device 2 can be removed from the treatment site.

[0113] FIGS. 53 and 54 illustrates that the deployment tool 134 can have a deployment rod key 176. The deployment rod key 176 can be configured to interference fit against the device key 52 when the expandable support device 2 and the deployment tool 134 are in a locked configuration, as shown in FIG. 54. As shown in FIG. 55, when the deployment rod 148 is rotated into an unlocked configuration, as shown by arrow, the deployment rod key 176 can be configured to translate through the device key port 56, and the device key 52 can translate through the deployment rod key port 178.

[0114] After being radially expanded, the expandable deployment device 2 can be detached from the deployment tool 134 by turning the deployment rod 148 to the unlocked configuration, and then proximally translating the deployment rod 148. The expandable support device 2 can be radially contracted into the recovery sheath 138 by turning the deployment rod 148 to the locked configuration, and then distally translating the recovery sheath 138 while holding and/or proximally translating the deployment rod 148.

[0115] FIGS. 56 though 58 illustrate an expandable support device 2 explanted from a bone 180 can have bone substantially surrounding the struts 16. The bone 180 can pass through the pores 14. The struts 16 and joints 18 can be forced through the bone 180 during deployment of the expandable support device 2 in the bone 180. The bone 180 can grow around the struts 16 and joints 18 after deployment.

[0116] FIG. 59 illustrates the struts 16 can deploy through the bone 180. When the struts 16 expand (e.g., during radial expansion of the expandable support device 170), the struts 16 can create voids or struts tracks 182. The struts 16 can have a wide enough dimension transverse to the direction of radial expansion that the strut tracks 182 can be large enough to access and fill partially or completely with any material (e.g., BMP, bone cement, morselized bone, bone growth matrix). The struck tracks 182 can also be filled partially or completely with the threads or longitudinal vanes 96.

[0117] FIG. 60 illustrates that the strut 16 can be configured to leave a large or small strut track 182 during radial expansion of the expandable support device 170. The width of the track 182 can correspond to the strut width. The struts 16 can have a narrow dimension transverse to the direction of radial expansion. For example, the strut 16 can have a diamond-shaped cross-section with a longer dimension in the radial dimension than the angular dimension (i.e., the strut dimension transverse to the radial dimension). The visco-elastic nature of bone (e.g., cancellous bone and/or cortical bone) can cause the bone to back-fill the tracks 182 as shown in FIG. 60.

[0118] FIG. 61 illustrates that the strut 16 can be configured to leave a nominal or no strut track during radial expansion of the expandable support device 170. The struts 16 can have a nominal or otherwise substantially no thickness in the angular dimension (i.e., the strut dimension transverse to the radial dimension).

[0119] The expandable support device 2 can also be used for various other medical and non-medical applications: to immobilize and/or stabilize orthopedic trauma, hip fractures and other trauma, clavicle fractures and other trauma, small bones (e.g., carpals, tarsals, talus, other hand, feet and ankle bones) fractures and other trauma, other long bone repair (e.g., internal bone splinting), spinal fusion, use as an intermedullary canal implant to anchor an artificial joint, use as a bone anchor for a tendon repair or ligament implant (e.g., for anterior cruciate ligament repair or replacement), or combinations thereof.

[0120] Any elements described herein as singular can be pluralized (i.e., anything described as “one” can be more than one). Any species element of a genus element can have the characteristics or elements of any other species element of that genus. The above-described configurations, elements or complete assemblies and methods and their elements for carrying out the invention, and variations of aspects of the invention can be combined and modified with each other in any combination. All devices, apparatuses, systems, and methods described herein can be used for medical (e.g., diagnostic, therapeutic or rehabilitative) or non-medical purposes.